维普中文期刊产品整合服务

Assessment of clinical outcomes of advanced hilar cholangiocarcinoma

查看全文 作  者:Kang-Jie [1]Chen;Fu-Chun [1]Yang;Yun-Sheng [1]Qin;Jing [1]Jin;Shu-Sen [1]Zheng 高影响力作者 机构地区:[1]Division of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine高影响力机构 出  处:《Hepatobiliary & Pancreatic Diseases International》索引2018年第17卷第2期,共8页高影响力期刊 基  金:supported by grants from the 12th Five-Year major project of the transformation of the primary health appropri-ate technology in Zhejiang Province;the National Natural Science Foundation for Young Scientists of China(81402350);the Natural Science Foundation for Young Scientists of Zhejiang Province(LQ13H160001) 摘  要:Background: Low resectability and poor survival outcome are common for hilar cholangiocarcinoma(HCCA), especially in advanced stages. The present study was to assess the clinical outcome of advanced HCCA, focusing on therapeutic modalities, survival analysis and prognostic assessment.Methods: Clinical data of 176 advanced HCCA patients who had been treated in our hospital between January 2013 and December 2015 were analyzed retrospectively. Prognostic effects of clinicopathological factors were explored by univariate and multivariate analysis. Survival predictors were evaluated by the receiver operating characteristic(ROC) curve.Results: The 3-year overall survival rate was 13% for patients with advanced HCCA. Preoperative total bilirubin(P = 0.009), hepatic artery invasion(P = 0.014) and treatment modalities(P = 0.020) were independent prognostic factors on overall survival. A model combining these independent prognostic factors(area under ROC curve: 0.748; 95% CI: 0.678–0.811; sensitivity: 82.3%, specificity: 53.5%) was highly predictive of tumor death. After R0 resection, the 3-year overall survival was up to 38%. Preoperative total bilirubin was still an independent negative factor, but not for hepatic artery invasion.Conclusions: Surgery is still the best treatment for advanced HCCA. Preoperative biliary drainage should be performed in highly-jaundiced patients to improve survival. Prediction of survival is improved significantly by a model that incorporates preoperative total bilirubin, hepatic artery invasion and treatment modalities. 关 键 词:HILAR CHOLANGIOCARCINOMA Hepatic artery RESECTION PREOPERATIVE BILIARY drainage PROGNOSTIC factors
相关文献

参考文献(32)

引证文献(5)

耦合文献(4)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费